Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BC LisPram in type 1 diabetes mellitus
NCT04972175Phase 1Unknown
- Sponsor
- Michael Tsoukas
- Start
- Jul 2021
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of BC LisPram in type 1 diabetes mellitus (T1D) (3 arms), sponsored by Michael Tsoukas. Primary endpoints: Pharmacokinetics of Pramlintide, Pharmacokinetics of Insulin and 7 more. Status: unknown.
02
Drugs
BC LisPram
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04972175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04972175.